The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer History ProjectGuest Editorial

Paul Calabresi: A founder and giant in the field of medical oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS
Celia and Paul Calabresi at the Matterhorn

The story of modern cancer therapy would not be complete without the inclusion of the work of Paul Calabresi and some insights about the challenges he faced, along with his accomplishments.

For this chapter in the Cancer History Project, I revised and extended a Memorial I wrote for Paul in 2006. I also had the pleasure of interviewing many who knew him well including his children: Steven Calabresi, Janice Calabresi Maggs and Peter A. Calabresi, MD. Others gave generously of their time to speak with me and share stories and experiences which I hope will add some richness to Paul’s contributions as an oncologist.

Read the full story here, with commentary by Wafik El-Deiry
Byline
Fred Schiffman, MD, MACP
Sigal Family Professor of Humanistic Medicine;
Vice Chairman of Medicine, Warren Alpert Medical School of Brown University; Medical Director of the Lifespan Cancer Institute; Associate Physician-in-Chief, The Miriam Hospital
Table of Contents

YOU MAY BE INTERESTED IN

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa
With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

Pfizer External Research & Grants’ “Improving Breast Cancer Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa,” powered by EveryGrant, has announced grants totaling more than $900,000 for addressing inequities and improving the quality of breast cancer care in Sub-Saharan Africa.
By Claire Marie Porter
ClinicalTrials & Tribulations

The other side of the patient portal: Reflections from a cancer center leader

It started innocuously enough. I looked in the mirror and noticed a pigmented area on my scalp just into the hairline. Like many patients, thoughts started running through my head: “Maybe it’s nothing.” Looking at my Outlook calendar, it was packed morning-to-night with meetings, patients, and travel, so I decided I would get that spot checked out the minute I had “time.” 
By Ruben A. Mesa
Cancer Policy

A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”

In the morning of May 28, presumably before turning off the lights and closing the office door, someone at the now defunct NCI Office of Communications and Public Liaision decided to post a farewell message to the cancer community.  The message, posted on multiple social media accounts, read: We’re taking a pause here - but...

By Jacquelyn Cobb
Byline
Fred Schiffman, MD, MACP
Sigal Family Professor of Humanistic Medicine;
Vice Chairman of Medicine, Warren Alpert Medical School of Brown University; Medical Director of the Lifespan Cancer Institute; Associate Physician-in-Chief, The Miriam Hospital
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account